This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallin, M.
Right arrow Articles by Struelens, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallin, M.
Right arrow Articles by Struelens, M. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2003, p. 3942-3944, Vol. 41, No. 8
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.8.3942-3944.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Clinical Impact of a PCR Assay for Identification of Staphylococcus aureus and Determination of Methicillin Resistance Directly from Blood Cultures

M. Hallin,1* N. Maes,1 B. Byl,2 F. Jacobs,2 Y. De Gheldre,1,{dagger} and M. J. Struelens1

Laboratory of Microbiology,1 Infectious Diseases Clinic, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium2

Received 31 January 2003/ Returned for modification 19 March 2003/ Accepted 22 May 2003

We evaluated the clinical usefulness of a PCR assay that discriminates Staphylococcus aureus from coagulase-negative staphylococci and detects methicillin resistance on blood cultures by measuring the adaptation of antimicrobial therapy based on the PCR results. Only 7 of 28 patients (25%) benefited from a modification of antibiotic therapy based on the PCR results, since empirical therapy was appropriate in a majority of cases.


* Corresponding author. Mailing address: Service de Microbiologie, Hôpital Erasme, 808 route de Lennik, 1070 Brussels, Belgium. Phone: 32 2 555 34 84. Fax: 32 2 555 31 10. E-mail: mahallin{at}ulb.ac.be.

{dagger} Present address: Laboratoire de Microbiologie, Cliniques Universitaires Mont-Godinne, 5530 Yvoir, Belgium.


Journal of Clinical Microbiology, August 2003, p. 3942-3944, Vol. 41, No. 8
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.8.3942-3944.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ruimy, R., Dos-Santos, M., Raskine, L., Bert, F., Masson, R., Elbaz, S., Bonnal, C., Lucet, J.-C., Lefort, A., Fantin, B., Wolff, M., Hornstein, M., Andremont, A. (2008). Accuracy and Potential Usefulness of Triplex Real-Time PCR for Improving Antibiotic Treatment of Patients with Blood Cultures Showing Clustered Gram-Positive Cocci on Direct Smears. J. Clin. Microbiol. 46: 2045-2051 [Abstract] [Full Text]  
  • Hallin, M., Deplano, A., Denis, O., De Mendonca, R., De Ryck, R., Struelens, M. J. (2007). Validation of Pulsed-Field Gel Electrophoresis and spa Typing for Long-Term, Nationwide Epidemiological Surveillance Studies of Staphylococcus aureus Infections. J. Clin. Microbiol. 45: 127-133 [Abstract] [Full Text]  
  • Varettas, K., Mukerjee, C., Taylor, P. C. (2005). Anticoagulant Carryover May Influence Clot Formation in Direct Tube Coagulase Tests from Blood Cultures. J. Clin. Microbiol. 43: 4613-4615 [Abstract] [Full Text]  
  • Peterson, L. R., Dalhoff, A. (2004). Towards targeted prescribing: will the cure for antimicrobial resistance be specific, directed therapy through improved diagnostic testing?. J Antimicrob Chemother 53: 902-905 [Abstract] [Full Text]